Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2015 Financial Results
Mar 02, 2016 12:01 pm UTC| Business
SAN DIEGO, March 02, 2016 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will...
Avalanche Biotechnologies to Present at Upcoming Investor Conferences
Mar 02, 2016 12:00 pm UTC| Business
MENLO PARK, Calif., March 02, 2016 -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a gene therapy company committed to discovering and developing novel medicines for patients with chronic or debilitating disease,...
Antares Pharma to Present at the Cowen and Company 36th Annual Healthcare Conference
Mar 02, 2016 12:00 pm UTC| Business
EWING, N.J., March 02, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 36th Annual Healthcare Conference on...
Spark Therapeutics, Inc. to Host Conference Call on March 9th at 8:30 a.m. to Discuss 2015 Results
Mar 02, 2016 12:00 pm UTC| Business
PHILADELPHIA, March 02, 2016 -- Spark Therapeutics (NASDAQ:ONCE) today announced that it will host a conference call on Wednesday, March 9, 2016 at 8:30 a.m. Eastern to report corporate and financial results for the...
SKY Perfect JSAT Awards Kratos Contract to Provide TT&C Antenna and RF System for JCSAT-16 Satellite
Mar 02, 2016 12:00 pm UTC| Business
SAN DIEGO, March 02, 2016 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its Kratos ISI business unit was awarded a contract by SKY...
Amedisys Closes Associated Home Care Acquisition
Mar 02, 2016 12:00 pm UTC| Business
BATON ROUGE, La., March 02, 2016 -- Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice companies, as of March 1, 2016, has closed on the previously announced acquisition of Associated Home...
NeuroDerm to Present at Upcoming Investor Conferences
Mar 02, 2016 12:00 pm UTC| Business
REHOVOT, Israel, March 02, 2016 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that CEO Oded S. Lieberman, PhD will...